19 trials changed in the last 30 days: 1 stopped, 8 with notable changes, 10 with minor changes only.
Trial terminated
Also in this update: Final enrollment: 6 participants — 6% of the 100 planned; Primary completion date changed from estimate of Jan 1, 2030 to Jul 8, 2026
University of North Carolina, Chapel HillNot specified NCT06696014 Registry history of NCT06696014 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Aug 15, 2026 to Mar 1, 2027
Also in this update: Enrollment closed, study ongoing; Study completion pushed from Feb 15, 2027 to Sep 15, 2027
University of North Carolina, Chapel HillNot applicable NCT06060860 Registry history of NCT06060860 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Sep 2026 to Sep 2027
University of North Carolina, Chapel HillNot applicable NCT06451523 Registry history of NCT06451523 on ClinicalTrials.gov (opens the registry)
Phase changed: not specified → not applicable
University of North Carolina, Chapel HillNot applicable NCT07661433 Registry history of NCT07661433 on ClinicalTrials.gov (opens the registry)
Recruitment opened
University of North Carolina, Chapel HillPhase 2 NCT07588568 Registry history of NCT07588568 on ClinicalTrials.gov (opens the registry)
Reclassified as terminated (was completed)
Also in this update: Results posted: Sep 28, 2026
University of North Carolina, Chapel HillNot applicable NCT06979154 Registry history of NCT06979154 on ClinicalTrials.gov (opens the registry)
Final enrollment: 23 participants — 4% of the 634 planned
Also in this update: Enrollment closed, study ongoing; Primary completion date changed from estimate of Jun 2028 to Sep 8, 2026
University of North Carolina, Chapel HillNot applicable NCT07237295 Registry history of NCT07237295 on ClinicalTrials.gov (opens the registry)
Results posted: Sep 30, 2026
University of North Carolina, Chapel HillNot applicable NCT06173544 Registry history of NCT06173544 on ClinicalTrials.gov (opens the registry)
Results posted: Sep 24, 2026
University of North Carolina, Chapel HillNot applicable NCT06264726 Registry history of NCT06264726 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Final enrollment: 50 participants (planned 56); Study completion date changed from estimate of Dec 2026 to Sep 24, 2026
University of North Carolina, Chapel HillPhase 4 NCT07213635 Registry history of NCT07213635 on ClinicalTrials.gov (opens the registry)
Completed without a posted recruiting period
Also in this update: Final enrollment: 1750 participants (planned 1500); Primary completion date changed from estimate of Nov 30, 2026 to Aug 27, 2026
University of North Carolina, Chapel HillNot applicable NCT07699198 Registry history of NCT07699198 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Final enrollment: 41 participants (planned 30); Primary completion date changed from estimate of Jun 30, 2026 to Feb 25, 2025
University of North Carolina, Chapel HillNot applicable NCT05570721 Registry history of NCT05570721 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Final enrollment: 76 participants (planned 106)
University of North Carolina, Chapel HillNot applicable NCT06880640 Registry history of NCT06880640 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Final enrollment: 44 participants (planned 120); Primary completion date changed from estimate of Mar 30, 2028 to Aug 28, 2026
University of North Carolina, Chapel HillNot applicable NCT07126587 Registry history of NCT07126587 on ClinicalTrials.gov (opens the registry)
Trial completed
University of North Carolina, Chapel HillNot applicable NCT05316571 Registry history of NCT05316571 on ClinicalTrials.gov (opens the registry)
Trial status changed: Enrolling by Invitation → Completed
Also in this update: Final enrollment: 75 participants (planned 60); Primary completion date changed from estimate of Jul 31, 2026 to Aug 31, 2026
University of North Carolina, Chapel HillNot applicable NCT06988163 Registry history of NCT06988163 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Final enrollment: 1191 participants (planned 1000)
University of North Carolina, Chapel HillNot applicable NCT07526584 Registry history of NCT07526584 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Jul 1, 2026 to Oct 31, 2026
University of North Carolina, Chapel HillNot applicable NCT06870344 Registry history of NCT06870344 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 6 → 11 locations
University of North Carolina, Chapel HillPhase 4 NCT07095361 Registry history of NCT07095361 on ClinicalTrials.gov (opens the registry)
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-14 | NCT07873632 Study to Evaluate the Effects of Oral Glyceryl Guiacolate (Guaifenesin, GGE) on Sputum… | Phase 4 | Not Yet Recruiting |
| 2026-10-09 | NCT07868536 Post-traumatic Estradiol Administration and Care Evaluation (PEACE) | Phase 2 | Not Yet Recruiting |
| Early Phase 1 | 1 | |
| Phase 1 | 6 | |
| Phase 1/2 | 1 | |
| Phase 2 | 11 | |
| Phase 3 | 2 | |
| Phase 4 | 14 |
Depression (13) · Obesity (10) · Diabetes (8) · Anxiety (7) · Cystic Fibrosis (5) · PTSD (5) · Type 2 Diabetes (5) · Crohn's Disease (4) · Heart Disease (4) · Dementia (3)